Skip to main content
Erschienen in: Journal of Neurology 11/2011

Open Access 01.11.2011 | Original Communication

Short- and long-lasting tinnitus relief induced by transcranial direct current stimulation

verfasst von: Pierre Garin, Chantal Gilain, Jean-Philippe Van Damme, Katalin de Fays, Jacques Jamart, Michel Ossemann, Yves Vandermeeren

Erschienen in: Journal of Neurology | Ausgabe 11/2011

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

A significant proportion of the population suffers from tinnitus, a bothersome auditory phantom perception that can severely alter the quality of life. Numerous experimental studies suggests that a maladaptive plasticity of the auditory and limbic cortical areas may underlie tinnitus. Accordingly, repetitive transcranial magnetic stimulation (rTMS) has been repeatedly used with success to reduce tinnitus intensity. The potential of transcranial direct current stimulation (tDCS), another promising method of noninvasive brain stimulation, to relieve tinnitus has not been explored systematically. In a double-blind, placebo-controlled and balanced order design, 20 patients suffering from chronic untreatable tinnitus were submitted to 20 minutes of 1 mA anodal, cathodal and sham tDCS targeting the left temporoparietal area. The primary outcome measure was a change in tinnitus intensity or discomfort assessed with a Visual Analogic Scale (VAS) change-scale immediately after tDCS and 1 hour later. Compared to sham tDCS, anodal tDCS significantly reduced tinnitus intensity immediately after stimulation; whereas cathodal tDCS failed to do so. The variances of the tinnitus intensity and discomfort VAS change-scales increased dramatically after anodal and cathodal tDCS, whereas they remained virtually unchanged after sham tDCS. Moreover, several patients unexpectedly reported longer-lasting effects (at least several days) such as tinnitus improvement, worsening, or changes in tinnitus features, more frequently after real than sham tDCS. Anodal tDCS is a promising therapeutic tool for modulating tinnitus perception. Moreover, both anodal and cathodal tDCS seem able to alter tinnitus perception and could, thus, be used to trigger plastic changes.

Introduction

Tinnitus is a bothersome auditory phantom perception (i.e., hearing a noise without an external source of sound) that can affect 10–15% of the general population [12]. Tinnitus can be a devastating pathology since a significant proportion of tinnitus sufferers develop sleep disturbances, depression, and other psychiatric comorbidities, and a small fraction commit suicide [8, 12]. Numerous drug regimens, behavioral therapies or noise-masking devices have been tried with an overall relatively disappointing lack of universal efficacy [7, 21]. Since there is currently no satisfactory treatment for tinnitus, the condition of these patients may be especially distressing.
This lack of efficient therapies for tinnitus partly originates from an incomplete understanding of the pathophysiology of tinnitus, which is only starting to be unveiled. Whereas an initial event in the inner ear or in peripheral auditory pathways may initiate tinnitus, current hypotheses suggest that tinnitus could be maintained by the development of an abnormal plasticity triggered by deafferentation in a wide network of cortical areas and possibly subcortical structures [6, 23, 32]. Studies in animal models and patients have demonstrated both loss of hair cells in the inner hear and abnormal plastic alterations of tonotopic maps in the auditory cortex [25, 31, 32], with the now classical “edge effect” which could be one of the mechanisms underlying tinnitus. A zone of the auditory cortex that used to represent a frequency band lost by deafferentation could be “invaded” by the adjacent frequency bands, leading to an enduring auditory phantom perception, i.e., to tinnitus [25, 32]. When comparing tinnitus patients with healthy volunteers, functional brain imaging studies using positron emission tomography (PET) or functional magnetic resonance imaging (fMRI) have consistently demonstrated abnormalities of the resting metabolism or activation in several brain structures, including the primary and secondary auditory cortices, limbic and emotional or attentional areas such as the dorsolateral prefrontal cortex, and subcortical structures [2325]. Whereas the abnormal activity disclosed in the auditory-related areas (primary and secondary auditory cortices) could underlie the phantom auditory perception itself, the abnormal activity observed in the areas supporting cognitive, attentional, and limbic processes could be involved in the unpleasant and distressing aspect of tinnitus [31, 32]. Evoked auditory potentials or magnetoencephalography also point toward the persistence of an abnormal electric activity in a distributed network in tinnitus patients [34, 39].
The discovery of a disordered excitability in the auditory pathways and maladaptive plastic changes in auditory and limbic cortical areas led to the exciting hypothesis that it should be possible to treat tinnitus by modulating these abnormalities through brain stimulations. Indeed, several studies demonstrated that a single session of repetitive transcranial magnetic stimulation (rTMS) induces a transient relief of tinnitus [9, 29]. However, the therapeutic effect of rTMS waned as time elapsed. Therefore, aiming to extend this transient beneficial effect, several teams successfully applied repeated sessions of rTMS and induced a prolonged relief in tinnitus patients [15, 17, 30, 33]. Direct electric brain stimulation with epidural electrodes implanted over the auditory cortical areas has also been applied successfully in tinnitus patients; however, this approach requires invasive neurosurgical procedures [5].
Ten years ago, another method of noninvasive transcranial brain stimulation re-emerged after a long eclipse period: transcranial direct current stimulation (tDCS) [27]. Transcranial direct current stimulation has been extensively used to explore the neurophysiological mechanisms that govern human brain plasticity, as well as for modulating brain excitability. When applied over the primary motor cortex (M1), anodal (cathodal) tDCS increases (decreases) M1 excitability beyond the period of stimulation [27]. Transcranial direct current stimulation is considered as a promising therapeutic tool for several neurological and psychiatric pathologies which are driven by or result from abnormal brain excitability such as stroke, Parkinson’s disease, chronic pain, and depression [10].
To date, only two studies explored the potential of tDCS to modulate tinnitus perception or discomfort: a pilot study targeting the left temporoparietal area (LTA) in 7 patients, with a washout period of a few minutes [9]; and a large study (n = 543) without a sham condition [37]. Since tDCS is easy to apply, is less expensive than rTMS, can be manipulated to design a high-quality sham condition necessary for therapeutic trials, and has—so far—not induced epileptic seizure, tDCS seems closer than rTMS in making the translation from bench to bedside, which is why we explored the therapeutic potential of tDCS in patients suffering from intractable tinnitus.

Patients and method

The research protocol was approved by the local ethical committee and conducted according to the recommendations of the Helsinki declaration. Tinnitus patients were recruited in the otorhinolaryngology outpatient consultation. Since we postulated that tinnitus is based on an abnormal plasticity triggered by auditory deafferentation, we included patients in whom a cochlear lesion could be objectified by hearing loss. Inclusion criteria were the following: (1) tinnitus that could not be cured by other means, (2) stable tinnitus for at least 2 months, (3) age 18–80 years, and (4) stable hypoacousia. Exclusion criteria were (1) Ménière’s disease or fluctuating audition, (2) pure transduction hearing loss, (3) hyperacousia, (4) major cognitive impairment or psychiatric disorders, (5) severe comorbidity (e.g., heart failure, unstable diabetes), (6) contraindications to tDCS, including epilepsy, (7) chronic intake of alcohol or drugs that chronically affect brain functions (e.g., antidepressants, antiepileptics) stopped less than 1 month ago, and (8) pregnancy.
The study assumed a double-blind, placebo-controlled, cross-over design. After a baseline evaluation with questionnaires (see below) at the otorhinolaryngology outpatient consultation, each patient underwent three sessions of tDCS (anodal, cathodal, and sham) in a balanced order, at 2 week intervals. Two weeks after the last tDCS session, the patients were evaluated again during a follow-up visit. A total of 21 tinnitus patients (5 females) signed informed consent and were enrolled after a structured interview as suggested by the Tinnitus Research Initiative (TRI) [20].
Transcranial direct current stimulation was delivered by an Eldith DC-Stimulator® (NeuroConn, Ilmenau, Germany) through electrodes embedded in sponges soaked with NaCl 0.9%. The target cortical area was the left temporoparietal area (LTA), defined as being halfway between C3 and T5 measured with the 10-20 international EEG system [9, 29]. A 35 cm2 electrode was positioned over the LTA and a 50 cm2 electrode was positioned on the right scalp between T4 and F8. In order to guarantee the double-blind aspect of the experiment, an experimenter initially introduced a real or sham code for each session. The order of the codes was balanced across patients and sessions. A second (blinded) experimenter collected the behavioral data. During real (anodal/cathodal) stimulation, the Eldith DC-Stimulator delivered 20 minutes of DC stimulation at 1 mA (1 mA plateau, fade in/out 8 s). For sham tDCS, the polarity of the LTA electrode was anodal in 50% of the patients; after a short up-ramp, brief current pulses (110 μA over 15 ms, peak current 3 ms) were delivered every 550 ms, eliciting a tingling sensation similar to that felt during real stimulation.
The primary outcome measure was a change in tinnitus intensity or discomfort assessed with a Visual Analogic Scale (VAS) change-scale immediately after tDCS and 1 hour later. The VAS change-scale ranged from “full relief” (+4) to “very strong deterioration” (−4), with 0 being “unchanged”. Secondary outcome measures included potential long-term effects over the 2 weeks following each tDCS session on a French translation of the Tinnitus Questionnaire (TQ) [11, 22] and the Beck Depression Inventory (BDI) [2], as well as free reports from patients. The TQ, BDI, and free reports were collected at inclusion and follow-up consultations, and before each tDCS session. The tinnitus patients were dichotomized into a “low, compensated” (TQ < 46) or “high, decompensated” (TQ ≥ 47) distress category, according to the burden of psychological and depressive features [38].
For statistical analysis, the VAS change-scales for tinnitus intensity and discomfort immediately and 1 hour after tDCS sessions, the TQ and BDI scores, were compared between anodal, cathodal and sham tDCS by Friedman test, followed in case of a statistically significant heterogeneity by 2 × 2 Wilcoxon signed rank tests. The Pitman–Morgan test using the Spearman correlation coefficient was used for comparing the variances of sham versus anodal, sham versus cathodal and anodal versus cathodal. Behavioral effects spontaneously reported were compared between anodal, cathodal, and sham tDCS by 2 × 2 binomial tests. All statistical tests are two-tailed and were performed by SPSS 15.0 statistical software (SPSS Inc., Chicago, IL, USA).

Results

One depressive female patient was excluded because she needed to start antidepressant therapy between the first and second tDCS sessions. The characteristics of the 20 patients who completed the study are listed in Table 1. The age of the patients was 50.9 ± 12.9 years; they suffered from tinnitus for at least 8 months. After dichotomization into distress category, the TQ scores were 36.4 ± 10.2 in compensated (TQ < 46, n = 13) and 56.6 ± 9.8 in decompensated (TQ ≥ 47, n = 7) tinnitus patients.
Table 1
Demographic data of patients and their tinnitus characteristics
 
Age (years)
Sex
Duration (years)
Origin
Lateralitya
Class of hearing loss right/leftb
Auditory curve right/leftc
Mean BDI
Mean TQ
Compens
1
48
M
1–2
Early presbyacusis
R = L
L/L
d/d
5.3
55.5
D
2
23
M
5–10
Unknown
L
P/L
_/a
1.0
39.0
C
3
29
F
>10
Otosclerosis (having had surgical treatment)
Head
L/M
_/d
4.0
44.0
C
4
45
M
1–2
Sudden hearing loss
L
N/N
s/s
1.0
18.5
C
5
59
M
<1
Presbyacusis
R = L
N/N
s/s
1.5
48.0
D
6
54
M
>10
Acoustic trauma
L
L/L
d/d
14.0
39.0
C
7
65
M
1–2
Presbyacusis
R
L/L
d/d
0.5
42.0
C
8
67
M
2–5
Presbyacusis
L
L/L
d/d
1.0
15.5
C
9
55
M
5–10
Presbyacusis + acoustic trauma
R = L
L/L
d/d
4.5
56.0
D
10
44
M
2–5
Unknown
L
N/N
s/s
0.5
24.5
C
11
49
M
>10
Presbyacusis + whiplash
R = L
L/L
d/d
4.3
42.0
C
12
75
M
>10
Presbyacusis
L
M/M
∧/d
7.0
45.0
C
13
56
M
>10
Acoustic trauma
R = L
N/N
a/_
5.5
44.5
C
14
61
M
5–10
Presbyacusis
Head
M/L
d/d
27.0
78.0
D
15
51
F
5–10
Presbyacusis
R > L
L/L
∧/∧
8.0
55.0
D
16
48
M
1–2
Acoustic trauma + whiplash
R < L
L/N
d/d
2.5
43.5
C
17
60
M
<1
Presbyacusis + acoustic trauma
R > L
L/N
_/d
8.0
51.0
D
18
35
F
>10
Unknown
Head
N/N
d/_
1.5
40.0
C
19
57
M
1–2
Presbyacusis + whiplash
R = L
N/N
d/d
3.0
53.0
D
20
37
F
>10
Whiplash
R > L
N/N
_/_
2.8
35.5
C
Mean BDI (Beck Depression Inventory)/mean TQ (Tinnitus Questionnaire) scores at baseline (mean of the scores at the NET visit and inclusion); compens compensated tinnitus, C compensated tinnitus (TQ < 46), D decompensated tinntitus (TQ > 47)
aLaterality: R right tinnitus, L left tinnitus, R = L bilateral tinnitus, R > L bilateral tinnitus with right predominance, R < L bilateral tinnitus with left predominance
bClass of hearing loss (mean of hearing loss at 1,000, 2,000 and 4,000 Hz); N normal hearing threshold (<20 dB) on average but with a hearing loss at least over a frequency range, L mild hearing loss (20–40 dB), M moderate hearing loss (41–70 dB), S severe hearing loss (70–90 db), P profound hearing loss (>90db)
cAuditory curves; d descending, a ascending, _ horizontal, inverted v-shape, s scotoma on 4 or 6 kHz
Transcranial direct current stimulation was well tolerated. One of the patients (#19) reported a transient instability after sham tDCS which resolved within 1 hour. Some patients mentioned transient or longer-lasting tinnitus worsening, mostly under cathodal tDCS (see below).
A global analysis demonstrated a significant effect (p = 0.013) for tinnitus intensity immediately after tDCS. When compared to sham tDCS, the VAS change-scale for tinnitus intensity significantly decreased immediately after anodal tDCS (p = 0.020). There was no statistically significant difference between sham and cathodal (p = 0.414) nor between anodal and cathodal tDCS (p = 0.132). One hour after tDCS, the VAS change-scale for intensity was not different anymore between anodal, cathodal, and sham tDCS (p = 0.543). Whereas, the temporal evolution of the VAS change-scales for discomfort were similar to those for tinnitus intensity (Fig. 1), there was no significant difference immediately after anodal, cathodal, or sham tDCS (p = 0.108), nor 1 hour later (p = 0.761).
While 7 patients were positive responders to anodal tDCS, 4 other patients reported a slight tinnitus worsening after anodal tDCS. Six patients were positive responders to cathodal tDCS; 5 patients were also positive responders to anodal tDCS. Five others patients reported slight tinnitus worsening after cathodal tDCS, 1 patient responded positively to anodal tDCS, and 2 patients experienced worsening after anodal tDCS.
As shown in Fig. 1, the temporal evolution of the variances of the tinnitus intensity and discomfort VAS change-scales were strikingly different under real (anodal and cathodal) and sham tDCS. Indeed, the variance remained virtually unchanged after sham tDCS but increased dramatically after anodal and cathodal tDCS. When compared to sham tDCS, the variances of the intensity VAS change-scales increased immediately after anodal and cathodal tDCS (p = 0.011 and p < 0.001, respectively) and kept increasing 1 hour later (p = 0.004 and p = 0.001). There was no statistically significant difference in the variances between anodal and cathodal tDCS (p > 0.283). For the discomfort VAS change-scale, the variances were not significantly different immediately after tDCS (p > 0.108). However, 1 hour later, the variance significantly increased after anodal (p = 0.004) and cathodal (p = 0.002) tDCS when compared to sham tDCS; again, there was no statistically significant difference between anodal and cathodal tDCS (p = 0.9).
Unexpectedly, several patients spontaneously reported either lasting changes of tinnitus characteristics (loudness, pitch, fluctuations, etc.) or improvement/worsening that persisted several days (see Table 2). After anodal tDCS, 6 patients reported prolonged positive effects, and 3 patients mentioned lasting negative effects. After cathodal tDCS, 2 patients reported a lasting negative effect and 3 patients a positive effect. After sham tDCS, 3 patients reported a protracted negative effect. Overall, patients reported long-lasting benefits more frequently after anodal than sham tDCS (p = 0.031), whereas there was no significant difference between sham and cathodal tDCS (p = 0.25), nor between anodal and cathodal tDCS (p = 0.375).
Table 2
Long-lasting effects of tDCS sessions reported spontaneously by tinnitus patients
 
Sham
Anodal
Cathodal
3
 
Improvement (intensity and discomfort) during 2 days
Tone different, higher pitch, balance left/right
5
 
Worsening (intensity and discomfort) during 10 days
During a few days: decreased intensity on the right side, possible increase on the left
7
Slight increase of intensity and higher pitch with less variation, during a few days
Worsening (discomfort) ≥15 days; very high pitch, lack of the tone variations
 
9
 
Worsening (intensity and discomfort) during 7 days
Worsening (intensity and discomfort) ≥15 days, lack of the tone variations
10
Increase of intensity during 7 days
Improvement (intensity and discomfort) during ≥15 days
Improvement (intensity and discomfort) ≥15 days; lower tone less uncomfortable
13
 
Clear “well-being” during the afternoons during ≥15 days
 
15
 
During a few days: decrease of intensity on the left, lower tone less uncomfortable
 
16
 
Complete but transient resolution of tinnitus a few hours later, alternation of resolution/relapses, better mood
Worsening (intensity and discomfort) during ≥15 days
17
 
Modulation of intensity, slight pain, progressive return to previous status
 
19
Transient instability after sham tDCS resolved in 1 hour; increase of intensity >1 hour
  
Long-lasting positive, negative or other effects (change in pitch, tone, side balance, qualities of tinnitus) spontaneously reported by the patients after sham, anodal and cathodal tDCS. Patients 1, 2, 4, 6, 8, 11, 12, 14, 18, and 20 did not report any lasting effects
When comparing the TQ and BDI scores evaluating the 2 week epochs following each tDCS session, there was no statistically significant difference between sham, anodal, and cathodal tDCS (all p > 0.229). However, as shown in Fig. 2, the mean TQ score decreased steadily and significantly (p = 0.008) from baseline (43.5 ± 13.9) to follow-up (37.3 ± 16.1). The level of depression and anxiety (BDI scores, Fig. 2) remained unchanged over time (p = 0.299).

Discussion

The current study shows a net beneficial short-term effect of anodal tDCS applied over the left LTA on tinnitus intensity in 7 out of 20 patients (“positive responder” rate 35%) and extends previous reports by suggesting unexpected longer-lasting effects of a single tDCS session. There was no difference in the TQ and BDI scores but the study was neither designed nor powered for that purpose. The decrease of TQ scores over time may reflect a so-called “Hawthorne effect” [3], i.e., a nonspecific improvement due to the patient’s involvement into the study and the care devoted to follow their level of well-being.
Two key differences with previous tDCS studies [9, 37] were the experimental design and the electrode montage. First, the current experiment assumed a double-blind, placebo-controlled, and cross-over design with a long washout period (2 weeks). This temporal aspect is especially important since the recent history of cortical excitability can shape (and even reverse) the direction of excitability changes induced by tDCS or rTMS, this phenomenon is known as homeostatic plasticity or metaplasticity [40]. The second key difference with previous studies, in which the two electrodes were of the same size, is that we positioned a medium (35 cm2) electrode over the left LTA and a larger (50 cm2) electrode over the right laterofrontal scalp. Recent tDCS experiments have demonstrated that the excitability of a cortical area under a large electrode remains unchanged, ensuring that this large electrode could be considered as a real “neutral” reference electrode [26]. Using a smaller electrode targeting the cortical area of interest and a large reference electrode helps to disambiguate the interpretation of previous tDCS studies in which a combined effect from both “active” electrodes with opposite polarities could not be ruled out. Another way to avoid this ambiguity is to use an extracephalic reference electrode, which seems to be a safe alternative [35]. In the current experiment, the effects observed on tinnitus intensity may be chiefly driven by the DC stimulation of the left LTA; however, a significant contribution of the right frontal cognitive and limbic areas involved the emotional aspects of tinnitus [31] can not be ruled out.
Both our responder rate (35% of the patients were “positive responders” to anodal tDCS) and effect size were comparable to those reported in previous rTMS [19, 28] and tDCS studies [9, 37]. Whereas relatively low, these responder rate and effect size still compare favorably with the lower rate of success of other therapeutic approaches. Moreover, it should be acknowledged that the therapeutic trials designed to modulate tinnitus with noninvasive transcranial brain stimulations are still in their infancy and that the optimal parameters (target area, intensity, duration, etc.) remain to be settled before launching large randomized control trials. Despite the current lack of such trial, some patient’s characteristics seem to predict a positive response to rTMS, such as tinnitus duration and normal hearing [18], whereas age, gender, and tinnitus duration, type and laterality are not predictive for tDCS [37].
Whereas a significant beneficial effect was observed exclusively for anodal tDCS, it is, however, striking to compare the stability of the variance under sham tDCS with the dynamical evolution of the variances after both anodal and cathodal tDCS (Fig. 1). Two hypotheses could explain this observation. The first one is that patients became aware of the real/sham nature of the stimulations. In order to avoid drawing their attention on this aspect, we kept talking with them during stimulation. We did not ask specifically what their guess was; therefore, this possibility cannot be formally excluded. However, this is unlikely for several reasons. First, the stimulation parameters used are considered as “classical” in tDCS experiments and have been proven safe for patient’s blinding, although a significant proportion of healthy volunteers may formulate a correct guess at 1 mA [1]. Second, during sham tDCS, the Eldith DC-Stimulator® delivered brief and ineffective current pulses inducing a similar itching sensation that improves the blinding procedure. Third, the order of the stimulations was balanced across patients and sessions, which decreases the likelihood of unblinding all the patients. Fourth, the behavioral data were collected in a double-blind fashion. Finally, after sham tDCS, 4 of 20 patients reported short-lasting effects and 3 longer-lasting effects, suggesting they did not guess the sham nature of that stimulation. Thus, it is unlikely that the differential temporal evolution of the variance between sham and real tDCS could be explained by an unblinding of the patients.
The second hypothesis to explain this increasing variance over time solely after real but not sham tDCS is that both anodal and cathodal tDCS interacted with the left LTA activity and triggered changes in tinnitus perception/discomfort which built up over at least 1 hour, but with divergent effects (favorable or unfavorable) in different patients. At the group level, in addition to an increase of variance over time suggesting an ongoing dynamical phenomenon, anodal tDCS resulted in a net favorable effect, whereas cathodal tDCS did not. Besides the “canonical” effects on M1 excitability in humans [27], anodal and cathodal tDCS may both have interfered with an ongoing state of abnormal excitability such as observed in tinnitus patients [31, 32]. This may be in line with the recent observation of large-scale network abnormalities as revealed by functional connectivity in tinnitus patients [36]. Given the fact that several patients also reported additional changes in their tinnitus features (pitch, loudness, laterality) after real tDCS, one could hypothesize that anodal and cathodal tDCS perturbed a maladaptive equilibrium state and opened the door for plastic changes to develop, some patients taking advantage and experiencing an improvement, while others reported a worsening or useless changes in tinnitus features. The reason why tDCS triggers beneficial changes in some patients and detrimental in others remains an open question; reminiscent of the issue why some patients respond to rTMS or tDCS and others do not. This could be related to the clinical history and tinnitus features [18, 37], to the particular excitability of network reorganization (more or less “limbic” or “auditory”) [31, 32], the recent history of the LTA or connected areas excitability changes (homeostatic plasticity) [40], or to their genetic background such as the polymorphism of the brain-derived neurotrophic factor [4].
If real tDCS triggered spontaneous plastic changes by disrupting an ongoing state of abnormal excitability, this could also potentially explain the unexpected long-term effects on tinnitus spontaneously reported by our patients. Recent studies with repeated rTMS sessions have demonstrated a remarkably high success rate with long-term benefits [16]. It is worth noting that long-lasting beneficial effects on tinnitus have been induced by repeated sessions of either low-frequency (“inhibitory”) rTMS or high-frequency (“excitatory”) rTMS in a study with a parallel group design [1315], suggesting that both low- and high-frequency rTMS could trigger plastic changes in tinnitus patients, just as we observed with a single session of anodal or cathodal tDCS.
It has been suggested that rTMS might exert a multimodal effect on tinnitus: directly on brain excitability and indirectly through acoustic stimuli and peripheral nerves stimulation [19]; however, the involvement of peripheral nerve stimulation is debated [33]. Transcranial direct current stimulation is less likely to benefit from such a potential multimodal effect since it does not deliver acoustic stimulation and since the itching sensation driven by DC stimulation of the scalp nerves rapidly fades. On the one hand, this may lessen the therapeutic potential of tDCS compared to rTMS. On the other hand, the conclusions from tDCS studies may be less contaminated by poorer sham conditions or multimodal effects.

Conclusion

In summary, both anodal and cathodal tDCS applied over the left LTA modulated the perceived tinnitus intensity when compared to sham tDCS; but solely anodal tDCS induced a significant tinnitus relief, whereas cathodal tDCS did not, despite the aforementioned dynamical modulation. These results demonstrate that tDCS can noninvasively modulate tinnitus perception. At first glance, these mixed results with tDCS may not seem encouraging from an individual patient’s perspective since some patients do not respond to tDCS and others may experience (transient) tinnitus worsening. However, these dynamic changes after anodal and cathodal tDCS when compared to sham stimulation may also be interpreted as a potential therapeutic opportunity to seize. Indeed, if tDCS applied in tinnitus patients triggers excitability changes, this may open a window for brain plasticity that could potentially be tuned toward improvement; one of the goals of future studies should be to optimize tDCS parameters for relieving tinnitus.

Acknowledgments

We would like to thank the patients who consented to take part to the experiment. We also would like to thank Professor Patrice Laloux for his unfailing support. Christian Deneffe’s assistance with the figures is gratefully appreciated. The work of YV and the acquisition of the tDCS device were supported by the following grants: Fonds de la Recherche Scientifique Médicale FRSM 3.4.525.08.F 2008 and 2010; Fondation van Goethem-Brichant 2007 grant; Université Catholique de Louvain (UCL) Fonds Spécial de Recherche FSR 2008 and 2010.

Conflict of interest

None.

Open Access

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Open AccessThis is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License (https://​creativecommons.​org/​licenses/​by-nc/​2.​0), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Neuer Inhalt

e.Med Neurologie & Psychiatrie

Kombi-Abonnement

Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

Weitere Produktempfehlungen anzeigen
Literatur
1.
Zurück zum Zitat Ambrus GG, Paulus W, Antal A (2010) Cutaneous perception thresholds of electrical stimulation methods: comparison of tDCS and tRNS. Clin Neurophysiol 121(11):1908–1914PubMedCrossRef Ambrus GG, Paulus W, Antal A (2010) Cutaneous perception thresholds of electrical stimulation methods: comparison of tDCS and tRNS. Clin Neurophysiol 121(11):1908–1914PubMedCrossRef
2.
Zurück zum Zitat Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMed Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMed
3.
Zurück zum Zitat Campbell JP, Maxey VA, Watson WA (1995) Hawthorne effect: implications for prehospital research. Ann Emerg Med 26:590–594PubMedCrossRef Campbell JP, Maxey VA, Watson WA (1995) Hawthorne effect: implications for prehospital research. Ann Emerg Med 26:590–594PubMedCrossRef
4.
Zurück zum Zitat Cheeran B, Talelli P, Mori F, Koch G, Suppa A, Edwards M, Houlden H, Bhatia K, Greenwood R, Rothwell JC (2008) A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS. J Physiol 586:5717–5725PubMedCrossRef Cheeran B, Talelli P, Mori F, Koch G, Suppa A, Edwards M, Houlden H, Bhatia K, Greenwood R, Rothwell JC (2008) A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS. J Physiol 586:5717–5725PubMedCrossRef
5.
Zurück zum Zitat De Ridder D, De Mulder G, Verstraeten E, Van der Kelen K, Sunaert S, Smits M, Kovacs S, Verlooy J, Van de Heyning P, Moller AR (2006) Primary and secondary auditory cortex stimulation for intractable tinnitus. ORL J Otorhinolaryngol Relat Spec 68:48–54 (discussion 54–55)PubMedCrossRef De Ridder D, De Mulder G, Verstraeten E, Van der Kelen K, Sunaert S, Smits M, Kovacs S, Verlooy J, Van de Heyning P, Moller AR (2006) Primary and secondary auditory cortex stimulation for intractable tinnitus. ORL J Otorhinolaryngol Relat Spec 68:48–54 (discussion 54–55)PubMedCrossRef
6.
7.
Zurück zum Zitat Elgoyhen AB, Langguth B (2010) Pharmacological approaches to the treatment of tinnitus. Drug Discov Today 15:300–305PubMedCrossRef Elgoyhen AB, Langguth B (2010) Pharmacological approaches to the treatment of tinnitus. Drug Discov Today 15:300–305PubMedCrossRef
8.
Zurück zum Zitat Frankenburg FR, Hegarty JD (1994) Tinnitus, psychosis, and suicide. Arch Intern Med 154:2371–2375PubMedCrossRef Frankenburg FR, Hegarty JD (1994) Tinnitus, psychosis, and suicide. Arch Intern Med 154:2371–2375PubMedCrossRef
9.
Zurück zum Zitat Fregni F, Marcondes R, Boggio PS, Marcolin MA, Rigonatti SP, Sanchez TG, Nitsche MA, Pascual-Leone A (2006) Transient tinnitus suppression induced by repetitive transcranial magnetic stimulation and transcranial direct current stimulation. Eur J Neurol 13:996–1001PubMedCrossRef Fregni F, Marcondes R, Boggio PS, Marcolin MA, Rigonatti SP, Sanchez TG, Nitsche MA, Pascual-Leone A (2006) Transient tinnitus suppression induced by repetitive transcranial magnetic stimulation and transcranial direct current stimulation. Eur J Neurol 13:996–1001PubMedCrossRef
10.
Zurück zum Zitat Fregni F, Pascual-Leone A (2007) Technology insight: noninvasive brain stimulation in neurology-perspectives on the therapeutic potential of rTMS and tDCS. Nat Clin Pract Neurol 3:383–393PubMedCrossRef Fregni F, Pascual-Leone A (2007) Technology insight: noninvasive brain stimulation in neurology-perspectives on the therapeutic potential of rTMS and tDCS. Nat Clin Pract Neurol 3:383–393PubMedCrossRef
11.
Zurück zum Zitat Goebel G, Hiller W (1994) The tinnitus questionnaire. A standard instrument for grading the degree of tinnitus. Results of a multicenter study with the tinnitus questionnaire. HNO 42:166–172PubMed Goebel G, Hiller W (1994) The tinnitus questionnaire. A standard instrument for grading the degree of tinnitus. Results of a multicenter study with the tinnitus questionnaire. HNO 42:166–172PubMed
12.
Zurück zum Zitat Henry JA, Dennis KC, Schechter MA (2005) General review of tinnitus: prevalence, mechanisms, effects, and management. J Speech Lang Hear Res 48:1204–1235PubMedCrossRef Henry JA, Dennis KC, Schechter MA (2005) General review of tinnitus: prevalence, mechanisms, effects, and management. J Speech Lang Hear Res 48:1204–1235PubMedCrossRef
13.
Zurück zum Zitat Khedr EM, Abo-Elfetoh N, Rothwell JC, El-Atar A, Sayed E, Khalifa H (2010) Contralateral versus ipsilateral rTMS of temporoparietal cortex for the treatment of chronic unilateral tinnitus: comparative study. Eur J Neurol 17:976–983PubMedCrossRef Khedr EM, Abo-Elfetoh N, Rothwell JC, El-Atar A, Sayed E, Khalifa H (2010) Contralateral versus ipsilateral rTMS of temporoparietal cortex for the treatment of chronic unilateral tinnitus: comparative study. Eur J Neurol 17:976–983PubMedCrossRef
14.
Zurück zum Zitat Khedr EM, Rothwell JC, Ahmed MA, Awad EM, Galal O (2008) Cortical excitability and transcallosal inhibition in chronic tinnitus: transcranial magnetic study. Neurophysiol Clin 38:243–248PubMedCrossRef Khedr EM, Rothwell JC, Ahmed MA, Awad EM, Galal O (2008) Cortical excitability and transcallosal inhibition in chronic tinnitus: transcranial magnetic study. Neurophysiol Clin 38:243–248PubMedCrossRef
15.
Zurück zum Zitat Khedr EM, Rothwell JC, Ahmed MA, El-Atar A (2008) Effect of daily repetitive transcranial magnetic stimulation for treatment of tinnitus: comparison of different stimulus frequencies. J Neurol Neurosurg Psychiatry 79:212–215PubMedCrossRef Khedr EM, Rothwell JC, Ahmed MA, El-Atar A (2008) Effect of daily repetitive transcranial magnetic stimulation for treatment of tinnitus: comparison of different stimulus frequencies. J Neurol Neurosurg Psychiatry 79:212–215PubMedCrossRef
16.
Zurück zum Zitat Khedr EM, Rothwell JC, El-Atar A (2009) One-year follow up of patients with chronic tinnitus treated with left temporoparietal rTMS. Eur J Neurol 16:404–408PubMedCrossRef Khedr EM, Rothwell JC, El-Atar A (2009) One-year follow up of patients with chronic tinnitus treated with left temporoparietal rTMS. Eur J Neurol 16:404–408PubMedCrossRef
17.
Zurück zum Zitat Kleinjung T, Eichhammer P, Langguth B, Jacob P, Marienhagen J, Hajak G, Wolf SR, Strutz J (2005) Long-term effects of repetitive transcranial magnetic stimulation (rTMS) in patients with chronic tinnitus. Otolaryngol Head Neck Surg 132:566–569PubMedCrossRef Kleinjung T, Eichhammer P, Langguth B, Jacob P, Marienhagen J, Hajak G, Wolf SR, Strutz J (2005) Long-term effects of repetitive transcranial magnetic stimulation (rTMS) in patients with chronic tinnitus. Otolaryngol Head Neck Surg 132:566–569PubMedCrossRef
18.
Zurück zum Zitat Kleinjung T, Steffens T, Sand P, Murthum T, Hajak G, Strutz J, Langguth B, Eichhammer P (2007) Which tinnitus patients benefit from transcranial magnetic stimulation? Otolaryngol Head Neck Surg 137:589–595PubMedCrossRef Kleinjung T, Steffens T, Sand P, Murthum T, Hajak G, Strutz J, Langguth B, Eichhammer P (2007) Which tinnitus patients benefit from transcranial magnetic stimulation? Otolaryngol Head Neck Surg 137:589–595PubMedCrossRef
19.
Zurück zum Zitat Langguth B, de Ridder D, Dornhoffer JL, Eichhammer P, Folmer RL, Frank E, Fregni F, Gerloff C, Khedr E, Kleinjung T, Landgrebe M, Lee S, Lefaucheur JP, Londero A, Marcondes R, Moller AR, Pascual-Leone A, Plewnia C, Rossi S, Sanchez T, Sand P, Schlee W, Pysch D, Steffens T, van de Heyning P, Hajak G (2008) Controversy: does repetitive transcranial magnetic stimulation/transcranial direct current stimulation show efficacy in treating tinnitus patients? Brain Stimul 1:192–205PubMedCrossRef Langguth B, de Ridder D, Dornhoffer JL, Eichhammer P, Folmer RL, Frank E, Fregni F, Gerloff C, Khedr E, Kleinjung T, Landgrebe M, Lee S, Lefaucheur JP, Londero A, Marcondes R, Moller AR, Pascual-Leone A, Plewnia C, Rossi S, Sanchez T, Sand P, Schlee W, Pysch D, Steffens T, van de Heyning P, Hajak G (2008) Controversy: does repetitive transcranial magnetic stimulation/transcranial direct current stimulation show efficacy in treating tinnitus patients? Brain Stimul 1:192–205PubMedCrossRef
20.
Zurück zum Zitat Langguth B, Goodey R, Azevedo A, Bjorne A, Cacace A, Crocetti A, Del Bo L, De Ridder D, Diges I, Elbert T, Flor H, Herraiz C, Ganz Sanchez T, Eichhammer P, Figueiredo R, Hajak G, Kleinjung T, Landgrebe M, Londero A, Lainez MJ, Mazzoli M, Meikle MB, Melcher J, Rauschecker JP, Sand PG, Struve M, Van de Heyning P, Van Dijk P, Vergara R (2007) Consensus for tinnitus patient assessment and treatment outcome measurement: Tinnitus Research Initiative meeting, Regensburg, July 2006. Prog Brain Res 166:525–536PubMedCrossRef Langguth B, Goodey R, Azevedo A, Bjorne A, Cacace A, Crocetti A, Del Bo L, De Ridder D, Diges I, Elbert T, Flor H, Herraiz C, Ganz Sanchez T, Eichhammer P, Figueiredo R, Hajak G, Kleinjung T, Landgrebe M, Londero A, Lainez MJ, Mazzoli M, Meikle MB, Melcher J, Rauschecker JP, Sand PG, Struve M, Van de Heyning P, Van Dijk P, Vergara R (2007) Consensus for tinnitus patient assessment and treatment outcome measurement: Tinnitus Research Initiative meeting, Regensburg, July 2006. Prog Brain Res 166:525–536PubMedCrossRef
21.
Zurück zum Zitat Martinez Devesa P, Waddell A, Perera R, Theodoulou M (2007) Cognitive behavioural therapy for tinnitus. Cochrane Database Syst Rev:CD005233 Martinez Devesa P, Waddell A, Perera R, Theodoulou M (2007) Cognitive behavioural therapy for tinnitus. Cochrane Database Syst Rev:CD005233
22.
Zurück zum Zitat Meeus O, Blaivie C, Van de Heyning P (2007) Validation of the Dutch and the French version of the Tinnitus Questionnaire. B-ENT 3(Suppl 7):11–17PubMed Meeus O, Blaivie C, Van de Heyning P (2007) Validation of the Dutch and the French version of the Tinnitus Questionnaire. B-ENT 3(Suppl 7):11–17PubMed
23.
Zurück zum Zitat Melcher JR, Sigalovsky IS, Guinan JJ Jr, Levine RA (2000) Lateralized tinnitus studied with functional magnetic resonance imaging: abnormal inferior colliculus activation. J Neurophysiol 83:1058–1072PubMed Melcher JR, Sigalovsky IS, Guinan JJ Jr, Levine RA (2000) Lateralized tinnitus studied with functional magnetic resonance imaging: abnormal inferior colliculus activation. J Neurophysiol 83:1058–1072PubMed
24.
Zurück zum Zitat Muhlau M, Rauschecker JP, Oestreicher E, Gaser C, Rottinger M, Wohlschlager AM, Simon F, Etgen T, Conrad B, Sander D (2006) Structural brain changes in tinnitus. Cereb Cortex 16:1283–1288PubMedCrossRef Muhlau M, Rauschecker JP, Oestreicher E, Gaser C, Rottinger M, Wohlschlager AM, Simon F, Etgen T, Conrad B, Sander D (2006) Structural brain changes in tinnitus. Cereb Cortex 16:1283–1288PubMedCrossRef
25.
Zurück zum Zitat Muhlnickel W, Elbert T, Taub E, Flor H (1998) Reorganization of auditory cortex in tinnitus. Proc Natl Acad Sci USA 95:10340–10343PubMedCrossRef Muhlnickel W, Elbert T, Taub E, Flor H (1998) Reorganization of auditory cortex in tinnitus. Proc Natl Acad Sci USA 95:10340–10343PubMedCrossRef
26.
Zurück zum Zitat Nitsche MA, Doemkes S, Karakose T, Antal A, Liebetanz D, Lang N, Tergau F, Paulus W (2007) Shaping the effects of transcranial direct current stimulation of the human motor cortex. J Neurophysiol 97:3109–3117PubMedCrossRef Nitsche MA, Doemkes S, Karakose T, Antal A, Liebetanz D, Lang N, Tergau F, Paulus W (2007) Shaping the effects of transcranial direct current stimulation of the human motor cortex. J Neurophysiol 97:3109–3117PubMedCrossRef
27.
Zurück zum Zitat Nitsche MA, Paulus W (2000) Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol 527(Pt 3):633–639PubMedCrossRef Nitsche MA, Paulus W (2000) Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol 527(Pt 3):633–639PubMedCrossRef
28.
Zurück zum Zitat Plewnia C (2010) Brain Stimulation: new vistas for the exploration and treatment of tinnitus. CNS Neurosci Ther (in press) Plewnia C (2010) Brain Stimulation: new vistas for the exploration and treatment of tinnitus. CNS Neurosci Ther (in press)
29.
Zurück zum Zitat Plewnia C, Bartels M, Gerloff C (2003) Transient suppression of tinnitus by transcranial magnetic stimulation. Ann Neurol 53:263–266PubMedCrossRef Plewnia C, Bartels M, Gerloff C (2003) Transient suppression of tinnitus by transcranial magnetic stimulation. Ann Neurol 53:263–266PubMedCrossRef
30.
Zurück zum Zitat Plewnia C, Reimold M, Najib A, Reischl G, Plontke SK, Gerloff C (2007) Moderate therapeutic efficacy of positron emission tomography-navigated repetitive transcranial magnetic stimulation for chronic tinnitus: a randomised, controlled pilot study. J Neurol Neurosurg Psychiatry 78:152–156PubMedCrossRef Plewnia C, Reimold M, Najib A, Reischl G, Plontke SK, Gerloff C (2007) Moderate therapeutic efficacy of positron emission tomography-navigated repetitive transcranial magnetic stimulation for chronic tinnitus: a randomised, controlled pilot study. J Neurol Neurosurg Psychiatry 78:152–156PubMedCrossRef
31.
Zurück zum Zitat Rauschecker JP, Leaver AM, Muhlau M (2010) Tuning out the noise: limbic-auditory interactions in tinnitus. Neuron 66:819–826PubMedCrossRef Rauschecker JP, Leaver AM, Muhlau M (2010) Tuning out the noise: limbic-auditory interactions in tinnitus. Neuron 66:819–826PubMedCrossRef
32.
Zurück zum Zitat Roberts LE, Eggermont JJ, Caspary DM, Shore SE, Melcher JR, Kaltenbach JA (2010) Ringing ears: the neuroscience of tinnitus. J Neurosci 30:14972–14979PubMedCrossRef Roberts LE, Eggermont JJ, Caspary DM, Shore SE, Melcher JR, Kaltenbach JA (2010) Ringing ears: the neuroscience of tinnitus. J Neurosci 30:14972–14979PubMedCrossRef
33.
Zurück zum Zitat Rossi S, De Capua A, Ulivelli M, Bartalini S, Falzarano V, Filippone G, Passero S (2007) Effects of repetitive transcranial magnetic stimulation on chronic tinnitus: a randomised, crossover, double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 78:857–863PubMedCrossRef Rossi S, De Capua A, Ulivelli M, Bartalini S, Falzarano V, Filippone G, Passero S (2007) Effects of repetitive transcranial magnetic stimulation on chronic tinnitus: a randomised, crossover, double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 78:857–863PubMedCrossRef
34.
Zurück zum Zitat Schlee W, Hartmann T, Langguth B, Weisz N (2009) Abnormal resting-state cortical coupling in chronic tinnitus. BMC Neurosci 10:11PubMedCrossRef Schlee W, Hartmann T, Langguth B, Weisz N (2009) Abnormal resting-state cortical coupling in chronic tinnitus. BMC Neurosci 10:11PubMedCrossRef
35.
Zurück zum Zitat Vandermeeren Y, Jamart J, Ossemann M (2010) Effect of tDCS with an extracephalic reference electrode on cardio-respiratory and autonomic functions. BMC Neurosci 11:38PubMedCrossRef Vandermeeren Y, Jamart J, Ossemann M (2010) Effect of tDCS with an extracephalic reference electrode on cardio-respiratory and autonomic functions. BMC Neurosci 11:38PubMedCrossRef
36.
Zurück zum Zitat Vanneste S, Plazier M, der Loo E, de Heyning PV, Congedo M, De Ridder D (2010) The neural correlates of tinnitus-related distress. Neuroimage 52:470–480PubMedCrossRef Vanneste S, Plazier M, der Loo E, de Heyning PV, Congedo M, De Ridder D (2010) The neural correlates of tinnitus-related distress. Neuroimage 52:470–480PubMedCrossRef
37.
Zurück zum Zitat Vanneste S, Plazier M, Ost J, van der Loo E, Van de Heyning P, De Ridder D (2010) Bilateral dorsolateral prefrontal cortex modulation for tinnitus by transcranial direct current stimulation: a preliminary clinical study. Exp Brain Res 202:779–785PubMedCrossRef Vanneste S, Plazier M, Ost J, van der Loo E, Van de Heyning P, De Ridder D (2010) Bilateral dorsolateral prefrontal cortex modulation for tinnitus by transcranial direct current stimulation: a preliminary clinical study. Exp Brain Res 202:779–785PubMedCrossRef
38.
Zurück zum Zitat Vanneste S, Plazier M, van der Loo E, Ost J, Van de Heyning P, De Ridder D (2010) Burst transcranial magnetic stimulation: which tinnitus characteristics influence the amount of transient tinnitus suppression? Eur J Neurol 17:1141–1147PubMedCrossRef Vanneste S, Plazier M, van der Loo E, Ost J, Van de Heyning P, De Ridder D (2010) Burst transcranial magnetic stimulation: which tinnitus characteristics influence the amount of transient tinnitus suppression? Eur J Neurol 17:1141–1147PubMedCrossRef
39.
Zurück zum Zitat Wienbruch C, Paul I, Weisz N, Elbert T, Roberts LE (2006) Frequency organization of the 40-Hz auditory steady-state response in normal hearing and in tinnitus. Neuroimage 33:180–194PubMedCrossRef Wienbruch C, Paul I, Weisz N, Elbert T, Roberts LE (2006) Frequency organization of the 40-Hz auditory steady-state response in normal hearing and in tinnitus. Neuroimage 33:180–194PubMedCrossRef
40.
Zurück zum Zitat Ziemann U, Siebner HR (2008) Modifying motor learning through gating and homeostatic metaplasticity. Brain Stimul 1:60–66PubMedCrossRef Ziemann U, Siebner HR (2008) Modifying motor learning through gating and homeostatic metaplasticity. Brain Stimul 1:60–66PubMedCrossRef
Metadaten
Titel
Short- and long-lasting tinnitus relief induced by transcranial direct current stimulation
verfasst von
Pierre Garin
Chantal Gilain
Jean-Philippe Van Damme
Katalin de Fays
Jacques Jamart
Michel Ossemann
Yves Vandermeeren
Publikationsdatum
01.11.2011
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 11/2011
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-011-6037-6

Weitere Artikel der Ausgabe 11/2011

Journal of Neurology 11/2011 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Vierten reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.